Report Overview:
A bioresorbable stent system is a medical device used to treat narrowed or blocked blood vessels, particularly in coronary arteries. Unlike traditional stents made of metal, bioresorbable stents are designed to gradually dissolve and be absorbed by the body over time, leaving behind a restored, natural blood vessel.
This report provides a deep insight into the global Bioresorbable Stent System market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
Market Value:
The Global Bioresorbable Stent System Market Size was estimated at USD 274.73 million in 2023 and is projected to reach USD 366.07 million by 2029, exhibiting a CAGR of 4.90% during the forecast period.
CAGR of 4.90%
(2022 – 2029)
By Types:
•Metal Based
•Polymer-based
Key players include:
• Lepu Medical Technology
• Abbott
• MeKo Laser Material Processing
• Q3 Medical Group
• Bioheart
• WEGO HEALTHCARE (SHENZHEN)
• Shandong Huaan Biotechnology
• Sino Medical Sciences Technology
• Nano and Advanced Materials Institute
